K Szymonowicz, S Oeck, NM Malewicz, V Jendrossek - Cancers, 2018 - mdpi.com
Genetic alterations driving aberrant activation of the survival kinase Protein Kinase B (Akt) are observed with high frequency during malignant transformation and cancer progression …
C Liu, R Liu, D Zhang, Q Deng, B Liu, HP Chao… - Nature …, 2017 - nature.com
MicroRNAs play important roles in regulating tumour development, progression and metastasis. Here we show that one of the miR-200 family members, miR-141, is under …
CA Sánchez, EI Andahur, R Valenzuela… - …, 2015 - pmc.ncbi.nlm.nih.gov
The different prostate cancer (PCa) cell populations (bulk and cancer stem cells, CSCs) release exosomes that contain miRNAs that could modify the local or premetastatic niche …
Androgen deprivation therapy or ADT is one of the cornerstones of management of locally advanced or metastatic prostate cancer, alongside radiation therapy. However, despite early …
Prostate cancer is one of the most commonly diagnosed cancers in men, and androgen deprivation therapy still represents the primary treatment for prostate cancer patients. This …
HJ Wu, PY Chu - International Journal of Molecular Sciences, 2019 - mdpi.com
Cholangiocarcinoma (CCA) is the second most common type of liver cancer, and is highly aggressive with very poor prognosis. CCA is classified into intrahepatic cholangiocarcinoma …
TL Wong, N Che, S Ma - Biochimica et Biophysica Acta (BBA)-Molecular …, 2017 - Elsevier
Cancer metabolism has been studied for years and adopted in the clinic for monitoring disease progression and therapy response. Despite our growing knowledge of a distinctly …
Prostate cancer (PCa) is the second most common cancer in men. Common treatments include active surveillance, surgery, or radiation. Androgen deprivation therapy and …
Cancer is among the highly complex disease and renal cell carcinoma is the sixth-leading cause of cancer death. In order to understand complex diseases such as cancer, diabetes …